{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T05:34:44Z","timestamp":1789882484024,"version":"4.0.1"},"reference-count":66,"publisher":"Walter de Gruyter GmbH","issue":"6","license":[{"start":{"date-parts":[[2018,8,29]],"date-time":"2018-08-29T00:00:00Z","timestamp":1535500800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Department of Medicine University of Florida","award":["Gatorade Trust"],"award-info":[{"award-number":["Gatorade Trust"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch. Immunol. Ther. Exp."],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1007\/s00005-018-0519-5","type":"journal-article","created":{"date-parts":[[2018,8,29]],"date-time":"2018-08-29T21:03:00Z","timestamp":1535576580000},"page":"415-421","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Innate Lymphoid Cells in Inflammatory Bowel Disease"],"prefix":"10.2478","volume":"66","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2234-4325","authenticated-orcid":false,"given":"Jian","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah C.","family":"Glover","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"374","published-online":{"date-parts":[[2018,8,29]]},"reference":[{"key":"519_CR1","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1038\/nrgastro.2015.34","volume":"12","author":"AN Ananthakrishnan","year":"2015","unstructured":"Ananthakrishnan AN (2015) Epidemiology and risk factors for IBD. Nat Rev Gastroenterol Hepatol 12:205\u2013217","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"519_CR2","doi-asserted-by":"publisher","first-page":"2613","DOI":"10.1007\/s10620-011-1636-8","volume":"56","author":"JC Andreu-Ballester","year":"2011","unstructured":"Andreu-Ballester JC, Amig\u00f3-Garc\u00eda V, Catal\u00e1n-Serra I et al (2011) Deficit of gammadelta T lymphocytes in the peripheral blood of patients with Crohn\u2019s disease. Dig Dis Sci 56:2613\u20132622","journal-title":"Dig Dis Sci"},{"key":"519_CR3","doi-asserted-by":"publisher","first-page":"e52332","DOI":"10.1371\/journal.pone.0052332","volume":"7","author":"JR Bailey","year":"2012","unstructured":"Bailey JR, Bland PW, Tarlton JF et al (2012) IL-13 promotes collagen accumulation in Crohn\u2019s disease fibrosis by down-regulation of fibroblast MMP synthesis: a role for innate lymphoid cells? PLoS One 7:e52332","journal-title":"PLoS One"},{"key":"519_CR4","doi-asserted-by":"publisher","first-page":"1590","DOI":"10.1016\/S0140-6736(12)60026-9","volume":"380","author":"DC Baumgart","year":"2012","unstructured":"Baumgart DC, Sandborn WJ (2012) Crohn\u2019s disease. Lancet 380:1590\u20131605","journal-title":"Lancet"},{"key":"519_CR5","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1038\/ni.2534","volume":"14","author":"JH Bernink","year":"2013","unstructured":"Bernink JH, Peters CP, Munneke M et al (2013) Human type 1 innate lymphoid cells accumulate in inflamed mucosal tissues. Nat Immunol 14:221\u2013229","journal-title":"Nat Immunol"},{"key":"519_CR6","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.immuni.2015.06.019","volume":"43","author":"JH Bernink","year":"2015","unstructured":"Bernink JH, Krabbendam L, Germar K et al (2015) Interleukin-12 and \u2013 23 Control plasticity of CD127(+) group 1 and group 3 innate lymphoid cells in the intestinal lamina propria. Immunity 43:146\u2013160","journal-title":"Immunity"},{"key":"519_CR7","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1038\/nrmicro2546","volume":"9","author":"CL Bevins","year":"2011","unstructured":"Bevins CL, Salzman NH (2011) Paneth cells, antimicrobial peptides and maintenance of intestinal homeostasis. Nat Rev Microbiol 9:356\u2013368","journal-title":"Nat Rev Microbiol"},{"key":"519_CR8","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1053\/gast.2003.50045","volume":"124","author":"DK Bonen","year":"2003","unstructured":"Bonen DK, Cho JH (2003) The genetics of inflammatory bowel disease. Gastroenterology 124:521\u2013536","journal-title":"Gastroenterology"},{"key":"519_CR9","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1172\/JCI91816","volume":"127","author":"DW Bruce","year":"2017","unstructured":"Bruce DW, Stefanski HE, Vincent BG et al (2017) Type 2 innate lymphoid cells treat and prevent acute gastrointestinal graft-versus-host disease. J Clin Invest 127:1813\u20131825","journal-title":"J Clin Invest"},{"key":"519_CR10","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1096\/fj.04-3260com","volume":"19","author":"M Bruewer","year":"2005","unstructured":"Bruewer M, Utech M, Ivanov AI et al (2005) Interferon-gamma induces internalization of epithelial tight junction proteins via a macropinocytosis-like process. FASEB J 19:923\u2013933","journal-title":"FASEB J"},{"key":"519_CR11","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1038\/nature07537","volume":"457","author":"M Cella","year":"2009","unstructured":"Cella M, Fuchs A, Vermi W et al (2009) A human natural killer cell subset provides an innate source of IL-22 for mucosal immunity. Nature 457:722\u2013725","journal-title":"Nature"},{"key":"519_CR12","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1038\/ni.1668","volume":"10","author":"T Cupedo","year":"2009","unstructured":"Cupedo T, Crellin NK, Papazian N et al (2009) Human fetal lymphoid tissue-inducer cells are interleukin 17-producing precursors to RORC + CD127 + natural killer-like cells. Nat Immunol 10:66\u201374","journal-title":"Nat Immunol"},{"key":"519_CR13","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/nrgastro.2015.186","volume":"13","author":"HS Souza de","year":"2016","unstructured":"de Souza HS, Fiocchi C (2016) Immunopathogenesis of IBD: current state of the art. Nat Rev Gastroenterol Hepatol 13:13\u201327","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"519_CR14","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.humimm.2015.10.020","volume":"77","author":"R Diaz-Pena","year":"2016","unstructured":"Diaz-Pena R, Vidal-Castineira JR, Moro-Garcia MA et al (2016) Significant association of the KIR2DL3\/HLA-C1 genotype with susceptibility to Crohn\u2019s disease. Hum Immunol 77:104\u2013109","journal-title":"Hum Immunol"},{"key":"519_CR15","first-page":"187","volume":"20","author":"S Egawa","year":"1986","unstructured":"Egawa S, Hiwatashi N (1986) Natural killer cell activity in patients with inflammatory bowel disease. J Clin Lab Immunol 20:187\u2013192","journal-title":"J Clin Lab Immunol"},{"key":"519_CR16","doi-asserted-by":"crossref","first-page":"3256","DOI":"10.4049\/jimmunol.161.7.3256","volume":"161","author":"MM Fort","year":"1998","unstructured":"Fort MM, Leach MW, Rennick DM (1998) A role for NK cells as regulators of CD4+ T cells in a transfer model of colitis. J Immunol 161:3256\u20133261","journal-title":"J Immunol"},{"key":"519_CR17","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1016\/j.immuni.2013.02.010","volume":"38","author":"A Fuchs","year":"2013","unstructured":"Fuchs A, Vermi W, Lee JS et al (2013) Intraepithelial type 1 innate lymphoid cells are a unique subset of IL-12- and IL-15-responsive IFN-gamma-producing cells. Immunity 38:769\u2013781","journal-title":"Immunity"},{"key":"519_CR18","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1084\/jem.20101712","volume":"208","author":"A Geremia","year":"2011","unstructured":"Geremia A, Arancibia-C\u00e1rcamo CV, Fleming MP et al (2011) IL-23-responsive innate lymphoid cells are increased in inflammatory bowel disease. J Exp Med 208:1127\u20131133","journal-title":"J Exp Med"},{"key":"519_CR19","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1084\/jem.20010938","volume":"195","author":"F Gerosa","year":"2002","unstructured":"Gerosa F, Baldani-Guerra B, Nisii C et al (2002) Reciprocal activating interaction between natural killer cells and dendritic cells. J Exp Med 195:327\u2013333","journal-title":"J Exp Med"},{"key":"519_CR20","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1016\/j.immuni.2013.05.013","volume":"38","author":"T Glatzer","year":"2013","unstructured":"Glatzer T, Killig M, Meisig J et al (2013) RORgammat(+) innate lymphoid cells acquire a proinflammatory program upon engagement of the activating receptor NKp44. Immunity 38:1223\u20131235","journal-title":"Immunity"},{"key":"519_CR21","doi-asserted-by":"publisher","first-page":"1254009","DOI":"10.1126\/science.1254009","volume":"345","author":"Y Goto","year":"2014","unstructured":"Goto Y, Obata T, Kunisawa J et al (2014) Innate lymphoid cells regulate intestinal epithelial cell glycosylation. Science 345:1254009","journal-title":"Science"},{"key":"519_CR22","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.immuni.2014.01.011","volume":"40","author":"TY Halim","year":"2014","unstructured":"Halim TY, Steer CA, Math\u00e4 L et al (2014) Group 2 innate lymphoid cells are critical for the initiation of adaptive T helper 2 cell-mediated allergic lung inflammation. Immunity 40:425\u2013435","journal-title":"Immunity"},{"key":"519_CR23","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1038\/nature12240","volume":"498","author":"MR Hepworth","year":"2013","unstructured":"Hepworth MR, Monticelli LA, Fung TC et al (2013) Innate lymphoid cells regulate CD4 + T-cell responses to intestinal commensal bacteria. Nature 498:113\u2013117","journal-title":"Nature"},{"key":"519_CR24","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1126\/science.aaa4812","volume":"348","author":"MR Hepworth","year":"2015","unstructured":"Hepworth MR, Fung TC, Masur SH et al (2015) Immune tolerance. Group 3 innate lymphoid cells mediate intestinal selection of commensal bacteria-specific CD4(+) T cells. Science 348:1031\u20131035","journal-title":"Science"},{"key":"519_CR25","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1007\/s00251-009-0396-5","volume":"61","author":"JA Hollenbach","year":"2009","unstructured":"Hollenbach JA, Ladner MB, Saeteurn K et al (2009) Susceptibility to Crohn\u2019s disease is mediated by KIR2DL2\/KIR2DL3 heterozygosity and the HLA-C ligand. Immunogenetics 61:663\u2013671","journal-title":"Immunogenetics"},{"key":"519_CR26","doi-asserted-by":"publisher","first-page":"72","DOI":"10.3389\/fimmu.2012.00072","volume":"3","author":"K Hoorweg","year":"2012","unstructured":"Hoorweg K, Peters CP, Cornelissen F et al (2012) Functional differences between human NKp44(-) and NKp44(+) RORC(+) innate lymphoid cells. Front Immunol 3:72","journal-title":"Front Immunol"},{"key":"519_CR27","doi-asserted-by":"publisher","first-page":"4584","DOI":"10.4049\/jimmunol.1601146","volume":"197","author":"M Kadivar","year":"2016","unstructured":"Kadivar M, Petersson J, Svensson L et al (2016) CD8alphabeta + gammadelta T cells: a novel T cell subset with a potential role in inflammatory bowel disease. J Immunol 197:4584\u20134592","journal-title":"J Immunol"},{"key":"519_CR28","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1038\/ni1197","volume":"6","author":"Y Laouar","year":"2005","unstructured":"Laouar Y, Sutterwala FS, Gorelik L et al (2005) Transforming growth factor-beta controls T helper type 1 cell development through regulation of natural killer cell interferon-gamma. Nat Immunol 6:600\u2013607","journal-title":"Nat Immunol"},{"key":"519_CR29","doi-asserted-by":"publisher","first-page":"e1404","DOI":"10.14800\/ics.1404","volume":"3","author":"J Li","year":"2016","unstructured":"Li J, Doty A, Glover SC (2016a) Aryl hydrocarbon receptor signaling involves in the human intestinal ILC3\/ILC1 conversion in the inflamed terminal ileum of Crohn\u2019s disease patients. Inflamm Cell Signal 3:e1404. https:\/\/doi.org\/10.14800\/ics.1404","journal-title":"Inflamm Cell Signal"},{"key":"519_CR30","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.cellimm.2016.05.001","volume":"304\u2013305","author":"J Li","year":"2016","unstructured":"Li J, Doty AL, Iqbal A et al (2016b) The differential frequency of Lineage(-)CRTH2(-)CD45(+)NKp44(-)CD117(-)CD127(+)ILC subset in the inflamed terminal ileum of patients with Crohn\u2019s disease. Cell Immunol 304\u2013305:63\u201368","journal-title":"Cell Immunol"},{"key":"519_CR31","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1111\/cei.12996","volume":"190","author":"J Li","year":"2017","unstructured":"Li J, Doty AL, Tang Y et al (2017a) Enrichment of IL-17A(+) IFN-gamma(+) and IL-22(+) IFN-gamma(+) T cell subsets is associated with reduction of NKp44(+) ILC3s in the terminal ileum of Crohn\u2019s disease patients. Clin Exp Immunol 190:143\u2013153","journal-title":"Clin Exp Immunol"},{"key":"519_CR32","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1007\/s10875-016-0365-3","volume":"37","author":"J Li","year":"2017","unstructured":"Li J, Shouval DS, Doty AL et al (2017b) Increased mucosal IL-22 production of an IL-10RA mutation patient following anakinra treatment suggests further mechanism for mucosal healing. J Clin Immunol 37:104\u2013107","journal-title":"J Clin Immunol"},{"key":"519_CR33","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1016\/j.immuni.2015.02.007","volume":"42","author":"H Maazi","year":"2015","unstructured":"Maazi H, Patel N, Sankaranarayanan I et al (2015) ICOS:ICOS-ligand interaction is required for type 2 innate lymphoid cell function, homeostasis, and induction of airway hyperreactivity. Immunity 42:538\u2013551","journal-title":"Immunity"},{"key":"519_CR34","doi-asserted-by":"publisher","first-page":"5862","DOI":"10.1038\/ncomms6862","volume":"6","author":"EC Mackley","year":"2015","unstructured":"Mackley EC, Houston S, Marriott CL et al (2015) CCR7-dependent trafficking of RORgamma(+) ILCs creates a unique microenvironment within mucosal draining lymph nodes. Nat Commun 6:5862","journal-title":"Nat Commun"},{"key":"519_CR35","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1111\/j.1365-2249.2012.04649.x","volume":"170","author":"ER Mann","year":"2012","unstructured":"Mann ER, McCarthy NE, Peake ST et al (2012) Skin- and gut-homing molecules on human circulating gammadelta T cells and their dysregulation in inflammatory bowel disease. Clin Exp Immunol 170:122\u2013130","journal-title":"Clin Exp Immunol"},{"key":"519_CR36","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.immuni.2017.07.005","volume":"47","author":"CE Martin","year":"2017","unstructured":"Martin CE, Spasova DS, Frimpong-Boateng K et al (2017) Interleukin-7 Availability is maintained by a hematopoietic cytokine sink comprising innate lymphoid cells and T cells. Immunity 47:171\u2013182 e4","journal-title":"Immunity"},{"key":"519_CR37","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1038\/ni1138","volume":"5","author":"A Martin-Fontecha","year":"2004","unstructured":"Martin-Fontecha A, Thomsen LL, Brett S et al (2004) Induced recruitment of NK cells to lymph nodes provides IFN-gamma for T(H)1 priming. Nat Immunol 5:1260\u20131265","journal-title":"Nat Immunol"},{"key":"519_CR38","doi-asserted-by":"publisher","first-page":"3215","DOI":"10.1172\/JCI80840","volume":"125","author":"NE McCarthy","year":"2015","unstructured":"McCarthy NE, Hedin CR, Sanders TJ et al (2015) Azathioprine therapy selectively ablates human Vdelta2(+) T cells in Crohn\u2019s disease. J Clin Invest 125:3215\u20133225","journal-title":"J Clin Invest"},{"key":"519_CR39","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1007\/BF03401672","volume":"3","author":"LD McVay","year":"1997","unstructured":"McVay LD, Li B, Biancaniello R et al (1997) Changes in human mucosal gamma delta T cell repertoire and function associated with the disease process in inflammatory bowel disease. Mol Med 3:183\u2013203","journal-title":"Mol Med"},{"key":"519_CR40","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.1097\/MIB.0000000000000105","volume":"20","author":"S Mizuno","year":"2014","unstructured":"Mizuno S, Mikami Y, Kamada N et al (2014) Cross-talk between RORgammat + innate lymphoid cells and intestinal macrophages induces mucosal IL-22 production in Crohn\u2019s disease. Inflamm Bowel Dis 20:1426\u20131434","journal-title":"Inflamm Bowel Dis"},{"key":"519_CR41","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1016\/j.jaci.2016.09.009","volume":"138","author":"J Mjosberg","year":"2016","unstructured":"Mjosberg J, Spits H (2016) Human innate lymphoid cells. J Allergy Clin Immunol 138:1265\u20131276","journal-title":"J Allergy Clin Immunol"},{"key":"519_CR42","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1016\/S1074-7613(03)00264-4","volume":"19","author":"R Mocikat","year":"2003","unstructured":"Mocikat R, Braum\u00fcller H, Gumy A et al (2003) Natural killer cells activated by MHC class I(low) targets prime dendritic cells to induce protective CD8 T cell responses. Immunity 19:561\u2013569","journal-title":"Immunity"},{"key":"519_CR43","doi-asserted-by":"publisher","first-page":"10762","DOI":"10.1073\/pnas.1509070112","volume":"112","author":"LA Monticelli","year":"2015","unstructured":"Monticelli LA, Osborne LC, Noti M et al (2015) IL-33 promotes an innate immune pathway of intestinal tissue protection dependent on amphiregulin-EGFR interactions. Proc Natl Acad Sci USA 112:10762\u201310767","journal-title":"Proc Natl Acad Sci USA"},{"key":"519_CR44","doi-asserted-by":"publisher","first-page":"2394","DOI":"10.1002\/eji.200636290","volume":"36","author":"B Morandi","year":"2006","unstructured":"Morandi B, Bougras G, Muller WA et al (2006) NK cells of human secondary lymphoid tissues enhance T cell polarization via IFN-gamma secretion. Eur J Immunol 36:2394\u20132400","journal-title":"Eur J Immunol"},{"key":"519_CR45","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1038\/sj.cdd.4402170","volume":"15","author":"A Moretta","year":"2008","unstructured":"Moretta A, Marcenaro E, Parolini S et al (2008) NK cells at the interface between innate and adaptive immunity. Cell Death Differ 15:226\u2013233","journal-title":"Cell Death Differ"},{"key":"519_CR46","doi-asserted-by":"publisher","first-page":"e0003627","DOI":"10.1371\/journal.pntd.0003627","volume":"9","author":"N Nausch","year":"2015","unstructured":"Nausch N, Appleby LJ, Sparks AM et al (2015) Group 2 innate lymphoid cell proportions are diminished in young helminth infected children and restored by curative anti-helminthic treatment. PLoS Negl Trop Dis 9:e0003627","journal-title":"PLoS Negl Trop Dis"},{"key":"519_CR47","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1111\/j.1365-2249.2009.04012.x","volume":"158","author":"SC Ng","year":"2009","unstructured":"Ng SC, Plamondon S, Al-Hassi HO et al (2009) A novel population of human CD56+ human leucocyte antigen D-related (HLA-DR+) colonic lamina propria cells is associated with inflammation in ulcerative colitis. Clin Exp Immunol 158:205\u2013218","journal-title":"Clin Exp Immunol"},{"key":"519_CR48","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.immuni.2014.06.016","volume":"41","author":"CJ Oliphant","year":"2014","unstructured":"Oliphant CJ, Hwang YY, Walker JA et al (2014) MHCII-mediated dialog between group 2 innate lymphoid cells and CD4(+) T cells potentiates type 2 immunity and promotes parasitic helminth expulsion. Immunity 41:283\u2013295","journal-title":"Immunity"},{"key":"519_CR49","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1016\/S0140-6736(12)60150-0","volume":"380","author":"I Ordas","year":"2012","unstructured":"Ordas I, Eckmann L, Talamini M et al (2012) Ulcerative colitis. Lancet 380:1606\u20131619","journal-title":"Lancet"},{"key":"519_CR50","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/1472-6793-6-2","volume":"6","author":"DM Patrick","year":"2006","unstructured":"Patrick DM, Leone AK, Shellenberger JJ et al (2006) Proinflammatory cytokines tumor necrosis factor-alpha and interferon-gamma modulate epithelial barrier function in Madin-Darby canine kidney cells through mitogen activated protein kinase signaling. BMC Physiol 6:2","journal-title":"BMC Physiol"},{"key":"519_CR51","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1038\/mi.2016.4","volume":"9","author":"VS Pelly","year":"2016","unstructured":"Pelly VS, Kannan Y, Coomes SM et al (2016) IL-4-producing ILC2s are required for the differentiation of TH2 cells following Heligmosomoides polygyrus infection. Mucosal Immunol 9:1407\u20131417","journal-title":"Mucosal Immunol"},{"key":"519_CR52","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1038\/nature13823","volume":"514","author":"JM Pickard","year":"2014","unstructured":"Pickard JM, Maurice CF, Kinnebrew MA et al (2014) Rapid fucosylation of intestinal epithelium sustains host-commensal symbiosis in sickness. Nature 514:638\u2013641","journal-title":"Nature"},{"key":"519_CR53","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1038\/ni.2002","volume":"12","author":"S Sawa","year":"2011","unstructured":"Sawa S, Lochner M, Satoh-Takayama N et al (2011) RORgammat + innate lymphoid cells regulate intestinal homeostasis by integrating negative signals from the symbiotic microbiota. Nat Immunol 12:320\u2013326","journal-title":"Nat Immunol"},{"key":"519_CR54","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.immuni.2016.11.005","volume":"46","author":"Y Simoni","year":"2017","unstructured":"Simoni Y, Fehlings M, Kl\u00f8verpris HN et al (2017) Human innate lymphoid cell subsets possess tissue-type based heterogeneity in phenotype and frequency. Immunity 46:148\u2013161","journal-title":"Immunity"},{"key":"519_CR55","doi-asserted-by":"publisher","first-page":"1869","DOI":"10.1084\/jem.20151403","volume":"212","author":"C Song","year":"2015","unstructured":"Song C, Lee JS, Gilfillan S et al (2015) Unique and redundant functions of NKp46 + ILC3s in models of intestinal inflammation. J Exp Med 212:1869\u20131882","journal-title":"J Exp Med"},{"key":"519_CR56","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1111\/j.1365-2036.2010.04499.x","volume":"33","author":"AW Steel","year":"2011","unstructured":"Steel AW, Mela CM, Lindsay JO et al (2011) Increased proportion of CD16(+) NK cells in the colonic lamina propria of inflammatory bowel disease patients, but not after azathioprine treatment. Aliment Pharmacol Ther 33:115\u2013126","journal-title":"Aliment Pharmacol Ther"},{"key":"519_CR57","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1053\/j.gastro.2010.05.040","volume":"139","author":"T Takayama","year":"2010","unstructured":"Takayama T, Kamada N, Chinen H et al (2010) Imbalance of NKp44(+)NKp46(-) and NKp44(-)NKp46(+) natural killer cells in the intestinal mucosa of patients with Crohn\u2019s disease. Gastroenterology 139:882\u2013892, 892 e1\u20133","journal-title":"Gastroenterology"},{"key":"519_CR58","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.1016\/S0140-6736(16)31711-1","volume":"389","author":"J Torres","year":"2017","unstructured":"Torres J, Mehandru S, Colombel JF et al (2017) Crohn\u2019s disease. Lancet 389:1741\u20131755","journal-title":"Lancet"},{"key":"519_CR59","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1038\/ni1582","volume":"9","author":"E Vivier","year":"2008","unstructured":"Vivier E, Tomasello E, Baratin M et al (2008) Functions of natural killer cells. Nat Immunol 9:503\u2013510","journal-title":"Nat Immunol"},{"key":"519_CR60","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1038\/nature16161","volume":"529","author":"J Moltke von","year":"2016","unstructured":"von Moltke J, Ji M, Liang HE et al (2016) Tuft-cell-derived IL-25 regulates an intestinal ILC2-epithelial response circuit. Nature 529:221\u2013225","journal-title":"Nature"},{"key":"519_CR61","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1084\/jem.20151448","volume":"213","author":"C Wilhelm","year":"2016","unstructured":"Wilhelm C, Harrison OJ, Schmitt V et al (2016) Critical role of fatty acid metabolism in ILC2-mediated barrier protection during malnutrition and helminth infection. J Exp Med 213:1409\u20131418","journal-title":"J Exp Med"},{"key":"519_CR62","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.humimm.2009.12.006","volume":"71","author":"TJ Wilson","year":"2010","unstructured":"Wilson TJ, Jobim M, Jobim LF et al (2010) Study of killer immunoglobulin-like receptor genes and human leukocyte antigens class I ligands in a Caucasian Brazilian population with Crohn\u2019s disease and ulcerative colitis. Hum Immunol 71:293\u2013297","journal-title":"Hum Immunol"},{"key":"519_CR63","doi-asserted-by":"publisher","first-page":"5079","DOI":"10.4049\/jimmunol.0901514","volume":"183","author":"DR Withers","year":"2009","unstructured":"Withers DR, Jaensson E, Gaspal F et al (2009) The survival of memory CD4 + T cells within the gut lamina propria requires OX40 and CD30 signals. J Immunol 183:5079\u20135084","journal-title":"J Immunol"},{"key":"519_CR64","doi-asserted-by":"publisher","first-page":"2094","DOI":"10.4049\/jimmunol.1201639","volume":"189","author":"DR Withers","year":"2012","unstructured":"Withers DR, Gaspal FM, Mackley EC et al (2012) Cutting edge: lymphoid tissue inducer cells maintain memory CD4 T cells within secondary lymphoid tissue. J Immunol 189:2094\u20132098","journal-title":"J Immunol"},{"key":"519_CR65","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.clim.2016.12.004","volume":"175","author":"S Yusung","year":"2017","unstructured":"Yusung S, McGovern D, Lin L et al (2017) NK cells are biologic and biochemical targets of 6-mercaptopurine in Crohn\u2019s disease patients. Clin Immunol 175:82\u201390","journal-title":"Clin Immunol"},{"key":"519_CR66","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1016\/j.immuni.2008.11.003","volume":"29","author":"LA Zenewicz","year":"2008","unstructured":"Zenewicz LA, Yancopoulos GD, Valenzuela DM et al (2008) Innate and adaptive interleukin-22 protects mice from inflammatory bowel disease. Immunity 29:947\u2013957","journal-title":"Immunity"}],"container-title":["Archivum Immunologiae et Therapiae Experimentalis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00005-018-0519-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00005-018-0519-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00005-018-0519-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,2]],"date-time":"2024-01-02T20:49:08Z","timestamp":1704228548000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00005-018-0519-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,29]]},"references-count":66,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["519"],"URL":"https:\/\/doi.org\/10.1007\/s00005-018-0519-5","relation":{},"ISSN":["0004-069X","1661-4917"],"issn-type":[{"value":"0004-069X","type":"print"},{"value":"1661-4917","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,29]]},"assertion":[{"value":"5 October 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 August 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declared no conflicts of interest in this study. Sarah Glover, DO is a consultant for AbbVie, Janssen and Takeda. Sarah Glover, DO has received grant support from AbbVie, Bristol Myers Squibb, Celgene, Gilead, Janssen, Genentech, Millennium, Pfizer, Receptos, Takeda and UCB.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}